Menu

TS Picks: February 24, 2016

High-profile stem cell research scandal; forthcoming direct-to-consumer genetics apps; GINA and life insurance

Feb 24, 2016
Tracy Vence

Human embryonic stem cellsWIKIMEDIA, NISSIM BENVENISTY

Selections from The Scientist’s reading list:
 

  • “As an outsider—young, female, and not an established stem-cell biologist—[Haruko] Obokata, the newspapers argued, was unhindered by conventional notions of what cells can and cannot do. Her fresh perspective, coupled with dogged work and natural genius, had conspired to create one of the great scientific breakthroughs of the twenty-first century.” —The New Yorker on STAP and stem cell research
     
  • MIT Technology Review this month named direct-to-consumer genetics apps, such as Helix’s forthcoming product, one of the top 10 breakthroughs of the year. (CRISPR and genetically engineered immune cells also made Tech Review’s 2016 list.)
     
  • While the Genetic Information Nondiscrimination Act (GINA) protects people from discrimination based on their genetics by employers and health insurers, its reach may be limited. Fast Company spoke with a woman who was reportedly denied life-insurance coverage because she carries the cancer-associated BRCA1 mutation and has a family history of the disease.

 

June 2019

Living with Bacteria

Can pathogens be converted to commensals?

Marketplace

Sponsored Product Updates

Gyros Protein Technologies introduces Gyrolab E. coli HCP Kit for automated impurity analysis of biotherapeutics
Gyros Protein Technologies introduces Gyrolab E. coli HCP Kit for automated impurity analysis of biotherapeutics
Ready-to-use immunoassay kit increases analytical output and productivity in bioprocess workflows. Kit developed as part of licensing and supply agreement with Cygnus Technologies
IDT launches ultra-high performance CRISPR Cas12a enzyme
IDT launches ultra-high performance CRISPR Cas12a enzyme
IDT’s new CRISPR Cas12a (Cpf1) Ultra enzyme can target new sites within the genome and with greater efficiency
Implen Launches New NanoPhotometer N120: The High Throughput Champion!
Implen Launches New NanoPhotometer N120: The High Throughput Champion!
Implen GmbH is excited to announce the release of the NanoPhotometer® N120, an absorbance based UV/VIS Multi Channel Spectrophotometer.
StemExpress Announces Release of New Frozen Leukopak® to Advance Research
StemExpress Announces Release of New Frozen Leukopak® to Advance Research
To continue to provide new products and services to further advance medical research around the world, today, StemExpress announced the release of their Frozen Leukopak®.